SCHEMBL5316176

SCHEMBL5316176

CS(=O)(=O)NC(=O)c1cnc(-c2ccccc2)nc1Nc1ccnc(NCCc2ccccn2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 5/20 0.44
TYRO3 Q06418 2/20 0.43
MAPK8 P45983 2/20 0.39
GBA1 P04062 1/20 0.39
LMNA P02545 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
HIF1A Q16665 1/20 0.38
JAK3 P52333 1/20 0.38
IGF1R P08069 1/20 0.37
TLR9 Q9NR96 1/20 0.37
OGA O60502 1/20 0.37
IRAK4 Q9NWZ3 1/20 0.37
JAK2 O60674 1/20 0.37
PTK2 Q05397 1/20 0.37
MKNK1 Q9BUB5 1/20 0.36
FLT3 P36888 1/20 0.36
MERTK Q12866 1/20 0.36
GAS6 Q14393 1/20 0.36
CDC7 O00311 1/20 0.36
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5913955 0.90 PDE4B (0.51) PDE4BTYRO3MAPK8GBA1HIF1A
SCHEMBL5264243 0.84 ALDH1A1 (0.48) TYRO3MAPK8LMNATDP1JAK3
SCHEMBL5914085 0.76 PDE4B (0.52) PDE4BTYRO3MAPK8GBA1JAK3
SCHEMBL5914236 0.75 PDE4B (0.55) PDE4BTYRO3GBA1HIF1AJAK3
SCHEMBL5261679 0.72 PDE4B (0.50) PDE4BTYRO3GBA1JAK3JAK2
SCHEMBL14656783 0.67 SYK (0.72) TYRO3MAPK8JAK3
SCHEMBL29761494 0.67 SYK (0.72) TYRO3MAPK8JAK3
SCHEMBL5914293 0.66 OGA (0.47) GBA1LMNAHIF1ATLR9OGA
SCHEMBL13743048 0.66 SMN1; SMN2 (0.48) GBA1HIF1AJAK3
SCHEMBL5089075 0.66 OGA (0.53) GBA1LMNAHIF1AOGAMKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1794135-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-06-13 EP disclosed
WO-2006037117-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2006-04-06 WO disclosed